Detalles de la búsqueda
1.
Impact of the number of lymph node dissections and a novel risk stratification on the prognosis in elderly locally advanced esophageal adenocarcinoma.
J Cancer
; 15(13): 4197-4204, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38947388
2.
Ribosomal protein L22 like 1: a promising biomarker for lung adenocarcinoma.
J Cancer
; 15(9): 2549-2560, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38577587
3.
Efficacy and safety of PD-1 inhibitors plus chemotherapy with or without endostatin for stage IV lung squamous cancer: a retrospective study.
Front Immunol
; 15: 1413204, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38911862
4.
The identification of genes associated T-cell exhaustion and construction of prognostic signature to predict immunotherapy response in lung adenocarcinoma.
Sci Rep
; 13(1): 13415, 2023 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592010
5.
LAPS score for individualized treatment of advanced EGFR-mutated non-small cell lung cancer receiving EGFR-TKIs with or without bevacizumab.
Ann Med
; 55(2): 2257227, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37713583
6.
First-generation EGFR-TKI plus bevacizumab and chemotherapy for advanced EGFR-mutated non-squamous non-small-cell lung cancer: a retrospective study.
Ann Med
; 55(2): 2243967, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37557185
7.
Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy.
Front Immunol
; 14: 1297188, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38022521
Resultados
1 -
7
de 7
1
Próxima >
>>